← Open Payments lookup

JEREMIAH SANDERS: Open Payments

NPI 1902392871 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,419 in 58 payments from 10 companies in 2025. Trend: 2023 $928 · 2024 $1,074 · 2025 $1,419

Food & beverage: $1,419
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$504
Vanda Pharmaceuticals Inc.15$319
Otsuka America Pharmaceutical, Inc.12$175
Teva Pharmaceuticals USA, Inc.5$174
ABBVIE INC.4$76
Lundbeck LLC4$71
Alkermes, Inc.2$40
Takeda Pharmaceuticals U.S.A., Inc.1$24
E.R. Squibb & Sons, L.L.C.1$23
Indivior Inc.1$15

Products named: CAPLYTA, FANAPT, REXULTI, UZEDY, VRAYLAR, AUSTEDO XR, LYBALVI, TRINTELLIX.

Industry payments across TX — which companies pay providers there.